Abstract:Previous studies suggest associations between self-reported sleep problems and poorer health, cognition, Alzheimer's disease pathology and dementia-related outcomes. It is important to develop a deeper understanding of the relationship between these complications and sleep disturbance, a modifiable risk factor, in late midlife, a time when Alzheimer's disease pathology may be accruing. The objectives of this study included application of unsupervised machine learning procedures to identify distinct subgroups of persons with problematic sleep and the association of these subgroups with concurrent measures of mental and physical health, cognition and PET-identified amyloid. Dementia-free participants from the Wisconsin Registry for Alzheimer's Prevention (n = 619) completed sleep questionnaires including the Insomnia Severity Index, Epworth Sleepiness Scale and Medical Outcomes Study Sleep Scale. K-means clustering analysis identified discrete sleep problem groups who were then compared across concurrent health outcomes (e.g. depression, self-rated health and insulin resistance), cognitive composite indices including episodic memory and executive function and, in a subset, Pittsburgh Compound B PET imaging to assess amyloid burden. Significant omnibus tests (P < 0.05) were followed with pairwise comparisons. Mean (SD) sample baseline sleep assessment age was 62.6 (6.7). Cluster analysis identified three groups: healthy sleepers [n = 262 (42.3%)], intermediate sleepers [n = 229 (37.0%)] and poor sleepers [n = 128 (20.7%)]. All omnibus tests comparing demographics and health measures across sleep groups were significant except for age, sex and apolipoprotein E e4 carriers; the poor sleepers group was worse than one or both of the other groups on all other measures, including measures of depression, self-reported health and memory complaints. The poor sleepers group had higher average body mass index, waist-hip ratio and homeostatic model assessment of insulin resistance. After adjusting for covariates, the poor sleepers group also performed worse on all concurrent cognitive composites except working memory. There were no differences between sleep groups on PET-based measures of amyloid. Sensitivity analyses indicated that while different clustering approaches resulted in different group assignments for some (predominantly the intermediate group), between-group patterns in outcomes were consistent. In conclusion, distinct sleep characteristics groups were identified with a sizable minority (20.7%) exhibiting poor sleep characteristics, and this group also exhibited the poorest concurrent mental and physical health and cognition, indicating substantial multi-morbidity; sleep group was not associated with amyloid PET estimates. Precision-based management of sleep and related factors may provide an opportunity for early intervention that could serve to delay or prevent clinical impairment.

DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue

Behavioral and genetic markers of sleepiness

[Positivity Analysis of Human Leukocyte Histocompatibility Antigen-Dqb1*0602 Allele in Chinese Patients with Narcolepsy].

Correlation analysis between HLA-DQA10102/DQB10602 genotypes and narcolepsy patients in China

Hla-Dq Association and Allele Competition in Chinese Narcolepsy

Genome-wide Association Study Ofhla-Dqb1*06:02Negative Essential Hypersomnia

Hla Dqb1*06:02 Negative Narcolepsy with Hypocretin/Orexin Deficiency

Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia

[HLA-DRB and -DQB allele contribution to narcolepsy susceptibility in Chinese patients with narcolepsy].

Associations of classical HLA alleles with sleep behaviours

Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services

Ventilatory Chemoresponsiveness, Narcolepsy-Cataplexy and Human Leukocyte Antigen DQB1*0602 Status

Predictors of interindividual differences in vulnerability to neurobehavioral consequences of chronic partial sleep restriction

Hla-Dpb1 and Hla Class I Confer Risk of and Protection from Narcolepsy

0969 Predicting Differences Between Objective and Subjective Sleep Parameters with Mental Health Questionnaires

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention

1012 Concordance and Test-Retest Consistency of Sleep Biomarker Based Phenotyping of Neurodegenerative Disorders

Insights into Behavioral Vulnerability to Differential Sleep Pressure and Circadian Phase from a Functional ADA Polymorphism

Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy

Differences in clinical and genetic characteristics between early- and late-onset narcolepsy in a Han Chinese cohort